TCR2 Therapeutics Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
March 22, 2022 at 04:15 pm IST
TCR2 Therapeutics Inc. reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported net loss was USD 27.74 million compared to USD 18.45 million a year ago. Basic loss per share from continuing operations was USD 0.72 compared to USD 0.55 a year ago.
For the full year, net loss was USD 99.81 million compared to USD 67.12 million a year ago. Basic loss per share from continuing operations was USD 2.63 compared to USD 2.4 a year ago.